Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Takako Ehara"'
Autor:
Tetsuya Tomita, Hiromi Rakugi, Hiroki Hayashi, Ryuichi Morishita, Jiao Sun, Yuka Yanagida, Shota Yoshida, Satoshi Baba, Akiko Tenma, Masayoshi Toyoura, Sotaro Kawabata, Takako Ehara, Ryoko Asaki, Makoto Sakaguchi, Hideki Tomioka, Munehisa Shimamura, Hironori Nakagami
Publikováno v:
RMD Open, Vol 9, Iss 1 (2023)
Objectives Spondyloarthritis (SpA) is known as series of immune-mediated inflammatory disease of the axial and peripheral joints. Human leucocyte antigen (HLA)-B27 is a genetic risk factor for SpA. Recent evidence suggests that the interleukin −17
Externí odkaz:
https://doaj.org/article/f1e439622aa643a9ab0805098beb61be
Autor:
Hiroki Hayashi, Jiao Sun, Yuka Yanagida, Shota Yoshida, Satoshi Baba, Akiko Tenma, Masayoshi Toyoura, Sotaro Kawabata, Takako Ehara, Ryoko Asaki, Makoto Sakaguchi, Hideki Tomioka, Munehisa Shimamura, Ryuichi Morishita, Hiromi Rakugi, Tetsuya Tomita, Hironori Nakagami
Publikováno v:
RMD Open. 9:e002851
ObjectivesSpondyloarthritis (SpA) is known as series of immune-mediated inflammatory disease of the axial and peripheral joints. Human leucocyte antigen (HLA)-B27 is a genetic risk factor for SpA. Recent evidence suggests that the interleukin −17 (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4647de4794424084ee32f1ced25e5dec
https://doi.org/10.1136/rmdopen-2022-002851
https://doi.org/10.1136/rmdopen-2022-002851
Autor:
Junichi Mineno, Ritsuko Kubota-Koketsu, Shota Yoshida, Munehisa Shimamura, Akiko Tenma, Jiao Sun, Yoshimi Saito, Hisashi Arase, Makoto Sakaguchi, Hideto Chono, Yasunori Amaishi, Tatsuo Shioda, Ryo Nakamaru, Yoshiharu Matsuura, Hiromi Rakugi, Hiroki Hayashi, Hironori Nakagami, Hideki Tomioka, Sotaro Kawabata, Chikako Ono, Takako Ehara, Yuka Yanagida, Ryoko Ide, Takao Komatsuno, Nan Ju, Takako Ootera, Ryuichi Morishita, Sachiko Okamoto
Publikováno v:
SSRN Electronic Journal.
As potential pandemic vaccines, DNA/RNA vaccines, viral vector vaccines and protein-based vaccines have been rapidly developed to prevent pandemic spread worldwide. In this study, we designed plasmid DNA vaccine targeting the SARS-CoV-2 Spike glycopr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee837f9ef13dbf1a068b23bd9094ea7c
https://doi.org/10.2139/ssrn.3900407
https://doi.org/10.2139/ssrn.3900407
Autor:
Takako Otera, Shota Yoshida, Yoshimi Saito, Yasunori Amaishi, Hiroki Hayashi, Ryo Nakamaru, Sotaro Kawabata, Chikako Ono, Takako Ehara, Sachiko Okamoto, Akiko Tenma, Hisashi Arase, Ritsuko Kubota-Kotetsu, Makoto Sakaguchi, Hironori Nakagami, Tatsuo Shioda, Junichi Mineno, Hideki Tomioka, Yuka Yanagida, Yoshiharu Matsuura, Munehisa Shimamura, Jiao Sun, Hideto Chono, Hiromi Rakugi, Ryuichi Morishita, Takao Komatsuno, Ryoko Ide
To fight against the worldwide COVID-19 pandemic, the development of an effective and safe vaccine against SARS-CoV-2 is required. As potential pandemic vaccines, DNA/RNA vaccines, viral vector vaccines and protein-based vaccines have been rapidly de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d920ce20492bd059943f874071917ef9
https://doi.org/10.1101/2020.10.21.347799
https://doi.org/10.1101/2020.10.21.347799
